New anticancer agents

Cancer Chemother Biol Response Modif. 1988:10:85-116.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenine
  • Antibiotics, Antineoplastic / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Biphenyl Compounds / therapeutic use
  • Depsipeptides*
  • Echinomycin / therapeutic use
  • Epirubicin / therapeutic use
  • Flavonoids / therapeutic use
  • Guanidines / therapeutic use
  • Humans
  • Idarubicin / therapeutic use
  • Imides*
  • Isoquinolines / therapeutic use
  • Menogaril
  • Naphthalimides
  • Nogalamycin / analogs & derivatives
  • Nogalamycin / therapeutic use
  • Organophosphonates
  • Pentostatin / therapeutic use
  • Peptides, Cyclic / therapeutic use
  • Polymers / therapeutic use
  • Vidarabine Phosphate / analogs & derivatives
  • Vidarabine Phosphate / therapeutic use

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Biphenyl Compounds
  • Depsipeptides
  • Flavonoids
  • Guanidines
  • Imides
  • Isoquinolines
  • Naphthalimides
  • Organophosphonates
  • Peptides, Cyclic
  • Polymers
  • Vidarabine Phosphate
  • amonafide
  • fludarabine phosphate
  • Pentostatin
  • Epirubicin
  • didemnins
  • Echinomycin
  • brequinar
  • flavone acetic acid
  • Menogaril
  • carboxyimamidate
  • Adenine
  • Nogalamycin
  • gusperimus
  • Idarubicin